Hyderabad-based Bharat Biotech had proposed to carry out a Phase-II/III clinical trial of Covaxin in the age group of 2 to 18 years. The trial will be conducted in 525 healthy volunteers
India News: NEW DELHI: Amid multiple states reporting a shortage of Covid-19 vaccine, Serum Institute and Bharat Biotech have submitted to the Centre their produc.
URL copied
Bharat Biotech s Covaxin approved for phase 2/3 trials on children
The Drugs Controller General of India (DGCI) has approved Bharat Biotech s COVID-19 vaccine
Covaxin for phase II/III clinical trial on those aged between two to 18 years. The trial will take place in 525 subjects at various sites, including AIIMS, Delhi, AIIMS, Patna and Meditrina Institute of Medical Sciences, Nagpur. In the trial, the vaccine will be given by intramuscular route in two doses at day 0 and day 28. The DCGI, after careful examination, has accepted the recommendation of Subject Expert Committee and accorded permission to conduct the Phase II/III clinical trial of Covaxin in the age group 2 to 18 years, to its manufacturer Bharat Biotech, the government said in a press note.
Vaccine shortage: Serum Institute to produce 10 crore doses by August, Bharat Biotech promises 7.8 crore jabs
The sources said the Union Health Ministry and the office of Drugs Controller General of India had sought from both the firms their production plan for June, July, August and September.
Share Via Email
| A+A A- By PTI
NEW DELHI: Amid multiple states reporting a shortage of COVID-19 vaccine, Serum Institute and Bharat Biotech have submitted to the Centre their production plan for the next four months, informing they can ramp it up to 10 crore and 7.8 crore doses respectively by August, official sources said on Wednesday
Haryana to float global tenders to procure COVID-19 vaccines
SECTIONS
Last Updated: May 13, 2021, 11:14 AM IST
Share
Synopsis
States like Uttar Pradesh, Maharashtra, Karnataka, Andhra Pradesh, Telangana, Tamil Nadu and Delhi have already opted for global tenders to meet their needs.
State Health Minister Anil Vij said that this will help the state vaccinate all 18+ citizens of the State at the earliest
Global tenders would be floated by the Haryana government for procurement of COVID-19 vaccines to ensure that all those above 18 in the state are inoculated, Health Minister Anil Vij said on Thursday. During the past few weeks, COVID cases in Haryana have witnessed a surge. The number of total active cases in the state, as on May 12, were 1,07,058.